SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?


To: Jenna who wrote (9082)5/6/1998 2:27:00 AM
From: Jenna  Read Replies (3) | Respond to of 120523
 
CBSL.. had a nice "pre-report" report also...
Complete Business backs upper end of EPS range.. All things considered the only companies that have failed to show any "anticipatory upswing" from the list were ORBKF and NICEY. They have shown an "anticipatory downswing." What's nice is that except for a 'fakeout' signal I got from NICEY the trend was clearly down most of the time for both of these. I was able to exit NICEY relatively unscathed as soon as it downticked. Should they continue down tomorrow, it's obvious they will not come into play at all.

FARMINGTON HILLS, Mich., May 5 (Reuters) - Complete Business Solutions Inc. (CBSL - news)
said Tuesday it is comfortable with the high end of analysts' earnings estimates for 1998, which range
between $0.56 and $0.70 per share.

The company, which went public in March of 1997, reported pro forma earnings of $0.71 a share in
1997, before a two-for-one stock split on March 19, 1998.

''Given our current trends in revenues and margins, we are comfortable with all of the published analyst
estimates to date, including recent updates at the high end of that range,'' Tim Manney, executive vice
president of finance and administration, said in a news release.



To: Jenna who wrote (9082)5/6/1998 6:21:00 AM
From: AlienTech  Read Replies (1) | Respond to of 120523
 
Is anyone playing CEPH? Look at the OI's on the MAY 10 and 12 1/2. Over 10k each. Guess the bets on again on the mayo's FDA approval.
The options seems to have a very high premium.